Home / Health / Covid-19: AstraZeneca to bring Dare-19 trial to India; 10 sites identified

Covid-19: AstraZeneca to bring Dare-19 trial to India; 10 sites identified

Called the Dare 19 trial, it is one of the several global research efforts by the British company to find a solution to treat Covid-19

Initiate suitable prosecution steps against AstraZeneca management, pleads FMRI

Premium

Ten sites have already been identified for the study in India

2 min read Last Updated : Jul 04 2020 | 6:55 PM IST

Biopharmaceutical major AstraZeneca, which has undertaken a global research study to test the effects of drug dapagliflozin in preventing serious complications such as organ failure in Covid-19 patients, is likely to begin the trials in India by July end.

Called the Dare 19 trial, it is one of the several global research efforts by the British company to find a solution to treat Covid-19. Ten sites have already been identified for the study in India and the process is on to get approval from the Drugs Controller General of India for this.

“We hope to start the process by the

Topics : Coronavirus AstraZeneca Biopharmaceutical COVID-19

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in